Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients
Poor peripheral blood stem cell (PBSC) mobilization predicts worse outcome for myeloma and lymphoma patients post autologous stem cell transplant (ASCT). We hypothesize that PBSC harvest using plerixafor and G-CSF in poor mobilizers may improve long-term outcome. We retrospectively analyzed the data...
Saved in:
| Main Authors: | Jan S. Moreb, Donya Salmasinia, Jack Hsu, Wei Hou, Christina Cline, Emma Rosenau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2011/517561 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells
by: MA Kucher, et al.
Published: (2016-04-01) -
Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01) -
Preemptive and upfront plerixafor: Safe and effective strategy for patients undergoing autologous stem cell transplant and at high risk for mobilization failure
by: Vipul Sheth, et al.
Published: (2020-01-01) -
Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients
by: Jaimie Cohen, et al.
Published: (2024-11-01) -
The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma
by: Ruiqi Wang, et al.
Published: (2025-08-01)